| All | Since 2020 | |
| Citation | 105 | 60 |
| h-index | 4 | 4 |
| i10-index | 3 | 2 |
WJAHR Citation 
Login
News & Updation
Best Article Awards
World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here
Indexing
Abstract
STUDY OF THE PREVALENCE AND RISK FACTORS OF ANTI TUBERCULOSIS DRUG INDUCED HEPATOTOXICITY AMONG PULMONARY TUBERCULOSIS PATIENTS ATTENDED AL-MADAEN GENERAL HOSPITAL IN BAGHDAD-IRAQ
*Dr. Bahaa Dawood Abdulkareem (M.B.Ch.B., C.A.B.H.S. /FM)., Dr. Huda Adnan Al-Mausawie (M.B.Ch.B., F.I.C.M.S. / FM)
ABSTRACT
Background: The first-line anti-TB drugs are potentially hepatotoxic and many factors have been reported to increase the risk of developing hepatotoxicity in patients with anti-TB therapy. Objectives: To determine the prevalence of hepatotoxicity among patients on anti-TB drug and to find any associated factors. Methods: A cross- sectional study held on 178 TB patients those admitted to Al-Madaen General hospital during the period from October 2023 to April 2024. Data were collected using a structured questionnaire, composed of socio- demographic characteristics of the patients and medical history. Data were analyzed by using Statistical Package of Social Sciences Version 29. Results: More than half (61%) of the patients were new cases, 72% of patients had no TB family history, 57% of patients use HRZE regime, 99.4% of the patient were with history of concomitant hepatotoxic drugs, 9% had abnormal liver function test with significant associations with gender, occupation and type of TB case. Conclusion: The mechanism of hepatotoxicity in female TB patients is unclear. Low socio-economic status (non-employed), and poor health TB patient were more likely to develop hepatotoxicity.
[Full Text Article] [Download Certificate]